Company / Tangible Book Value per Share
Aquestive Therapeutics, Inc. Tangible Book Value per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
-$0.37
FY2025
5-year range
-$2.88 / -$0.37
FY2021-FY2025
Trend
+58.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Tangible Book Value per Share has increased for 3 consecutive years, from $-2.88 in FY2022 to $-0.37 in FY2025.
Based on SEC 10-K filings.
-0.37 in FY2025.
Improved from $-1.94 to $-0.37 over the past 2 years.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Aquestive Therapeutics, Inc.'s tangible book value per share has grown for 3 consecutive years.
- In FY2025, tangible book value per share increased 58.0% year-over-year.
- Peak tangible book value per share was recorded in FY2019.
- Lowest tangible book value per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.37 | +58.0% |
| FY2024 | -$0.88 | +54.8% |
| FY2023 | -$1.94 | +32.5% |
| FY2022 | -$2.88 | -105.0% |
| FY2021 | -$1.40 | -669.1% |
| FY2020 | -$0.18 | -145.2% |
| FY2019 | $0.40 | +114.7% |
| FY2018 | -$2.75 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026